490
Views
30
CrossRef citations to date
0
Altmetric
Article

Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China

, , , , , , & show all
Pages 485-489 | Received 25 May 2015, Accepted 26 Jul 2015, Published online: 26 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jason P. Chua, Hortense De Calbiac, Edor Kabashi & Sami J. Barmada. (2022) Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy 18:2, pages 254-282.
Read now
. (2019) Theme 2 Genetics and genomics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:sup1, pages 114-134.
Read now
Hang Zhang, Wanshi Cai, Siyu Chen, Jialong Liang, Zhanjun Wang, Yuting Ren, Wenxiu Liu, Xiaolan Zhang, Zhongsheng Sun & Xusheng Huang. (2018) Screening for possible oligogenic pathogenesis in Chinese sporadic ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 419-425.
Read now
Jennifer A. Fifita, Kelly L. Williams, Vinod Sundaramoorthy, Emily P. Mccann, Garth A. Nicholson, Julie D. Atkin & Ian P. Blair. (2017) A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:1-2, pages 126-133.
Read now

Articles from other publishers (26)

Di He, Yining Liu, Siqi Dong, Dongchao Shen, Xunzhe Yang, Meng Hao, Xianhong Yin, Xinyi He, Yi Li, Yi Wang, Mingsheng Liu, Jiucun Wang, Xiangjun Chen & Liying Cui. (2023) The prognostic value of systematic genetic screening in amyotrophic lateral sclerosis patients. Journal of Neurology.
Crossref
Sumit Kinger, Ankur Rakesh Dubey, Prashant Kumar, Yuvraj Anandrao Jagtap, Akash Choudhary, Amit Kumar, Vijay Kumar Prajapati, Rohan Dhiman & Amit Mishra. (2023) Molecular Chaperones’ Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis. Cells 12:9, pages 1302.
Crossref
Su Min Lim, Minyeop Nahm & Seung Hyun Kim. (2023) Proteostasis and Ribostasis Impairment as Common Cell Death Mechanisms in Neurodegenerative Diseases. Journal of Clinical Neurology 19:2, pages 101.
Crossref
Lu Yang, Yanfei Cheng, Xinmiao Jia, Xudong Liu, Xiuli Li, Kang Zhang, Dongchao Shen, Mingsheng Liu, Yuzhou Guan, Qing Liu, Liying Cui & Xiaoguang Li. (2021) Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China. Neurobiology of Aging 97, pages 149.e1-149.e8.
Crossref
Xiaolu Liu, Ji He, Lu Chen, Nan Zhang, Lu Tang, Xiangyi Liu, Yan Ma & Dongsheng Fan. (2021) TBK1 variants in Chinese patients with amyotrophic lateral sclerosis. Neurobiology of Aging 97, pages 149.e9-149.e15.
Crossref
Garam Kim, Olivia Gautier, Eduardo Tassoni-Tsuchida, X. Rosa Ma & Aaron D. Gitler. (2020) ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron 108:5, pages 822-842.
Crossref
Qingyi Guo, Jincheng Wang & Qinjie Weng. (2020) The diverse role of optineurin in pathogenesis of disease. Biochemical Pharmacology 180, pages 114157.
Crossref
Owen Connolly, Laura Le Gall, Gavin McCluskey, Colette G Donaghy, William J Duddy & Stephanie Duguez. (2020) A Systematic Review of Genotype–Phenotype Correlation across Cohorts Having Causal Mutations of Different Genes in ALS. Journal of Personalized Medicine 10:3, pages 58.
Crossref
Antonio Canosa, Maurizio Grassano, Marco Barberis, Maura Brunetti, Umberto Manera, Rosario Vasta, Stefania Cammarosano, Giovanni De Marco, Andrea Calvo, Adriano Chiò & Cristina Moglia. (2020) A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation. Journal of Clinical Neuroscience 75, pages 223-225.
Crossref
Shu‐Man Feng, Chun‐Hui Che, Shu‐Yan Feng, Chang‐Yun Liu, Liu‐Yi Li, Yuan‐Xiao Li, Hua‐Pin Huang & Zhang‐Yu Zou. (2019) Novel mutation in optineurin causing aggressive ALS+/−frontotemporal dementia. Annals of Clinical and Translational Neurology 6:12, pages 2377-2383.
Crossref
Marie Ryan, Tatiana Zaldívar Vaillant, Russell L McLaughlin, Mark A Doherty, James Rooney, Mark Heverin, Joel Gutierrez, Gloria Esther Lara-Fernández, Mariana Pita Rodríguez, Jochen Hackembruch, Abayubá Perna, Maria Cristina Vazquez, Marco Musio, Carlos N Ketzoian, Giancarlo Logroscino & Orla Hardiman. (2019) Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. Journal of Neurology, Neurosurgery & Psychiatry 90:6, pages 659-665.
Crossref
Qianqian Wei, Xueping Chen, Yongping Chen, Ruwei Ou, Bei Cao, Yanbing Hou, Lingyu Zhang & Hui-Fang Shang. (2019) Unique characteristics of the genetics epidemiology of amyotrophic lateral sclerosis in China. Science China Life Sciences 62:4, pages 517-525.
Crossref
Archana Prasad, Vidhya Bharathi, Vishwanath Sivalingam, Amandeep Girdhar & Basant K. Patel. (2019) Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 12.
Crossref
Priyam Narain, Ashutosh Pandey, Shruti Gupta, James Gomes, Rohit Bhatia & Perumal Vivekanandan. (2018) Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosis. Neurobiology of Aging 71, pages 265.e9-265.e14.
Crossref
Xiaolu Liu, Ji He, Fen-Biao Gao, Aaron D. Gitler & Dongsheng Fan. (2018) The epidemiology and genetics of Amyotrophic lateral sclerosis in China. Brain Research 1693, pages 121-126.
Crossref
Danyang Tian, Jiao Li, Lu Tang, Nan Zhang & Dongsheng Fan. (2018) Screening for CCNF Mutations in a Chinese Amyotrophic Lateral Sclerosis Cohort. Frontiers in Aging Neuroscience 10.
Crossref
Robert Weil, Emmanuel Laplantine, Shannel Curic & Pierre Génin. (2018) Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer. Frontiers in Immunology 9.
Crossref
Reka P. Toth & Julie D. Atkin. (2018) Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. Frontiers in Immunology 9.
Crossref
Lianping Xu, Jiao Li, Danyang Tian, Lu Chen, Lu Tang & Dongsheng Fan. (2018) The rs696880 Polymorphism in the Nogo-A Receptor Gene (RTN4R) Is Associated With Susceptibility to Sporadic Amyotrophic Lateral Sclerosis in the Chinese Population. Frontiers in Aging Neuroscience 10.
Crossref
Sali M. K. Farhan, Tania F. Gendron, Leonard Petrucelli, Robert A. Hegele & Michael J. Strong. (2018) OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177:1, pages 75-85.
Crossref
Zhiqiang Deng, Patricia Sheehan, Shi Chen & Zhenyu Yue. (2017) Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?. Molecular Neurodegeneration 12:1.
Crossref
Xiangyi Liu, Lipeng Yang, Lu Tang, Lu Chen, Xiaolu Liu & Dongsheng Fan. (2017) DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis. PLOS ONE 12:8, pages e0182572.
Crossref
Zhiqiang Deng, Kerry Purtell, Veronik Lachance, Mitchell S. Wold, Shi Chen & Zhenyu Yue. (2017) Autophagy Receptors and Neurodegenerative Diseases. Trends in Cell Biology 27:7, pages 491-504.
Crossref
Andrea Markovinovic, Raffaello Cimbro, Tereza Ljutic, Jasna Kriz, Boris Rogelj & Ivana Munitic. (2017) Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Progress in Neurobiology 154, pages 1-20.
Crossref
Yuriko Minegishi, Mao Nakayama, Daisuke Iejima, Kazuhide Kawase & Takeshi Iwata. (2016) Significance of optineurin mutations in glaucoma and other diseases. Progress in Retinal and Eye Research 55, pages 149-181.
Crossref
N Shahrizaila, G Sobue, S Kuwabara, S H Kim, Carol Birks, D S Fan, J S Bae, C J Hu, M Gourie-Devi, Y Noto, K Shibuya, K J Goh, R Kaji, CP Tsai, L Cui, P Talman, R D Henderson, S Vucic & M C Kiernan. (2016) Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 821-830.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.